The Transmodulation of HER2 and EGFR by Substance P in Breast Cancer Cells Requires c-Src and Metalloproteinase Activation

• Susana Garcia-Recio ,

  * E-mail: sugarcia@clinic.ub.es (SGR); gascon@clinic.ub.es (PG)

  Affiliations Department of Medical Oncology, Hospital Clínic, Barcelona, Spain, Institut d’Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain

  ⨯
• Eva M. Pastor-Arroyo,

  Affiliations Department of Medical Oncology, Hospital Clínic, Barcelona, Spain, Institut d’Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain

  ⨯
• Mercedes Marín-Aguilera,

  Affiliations Department of Medical Oncology, Hospital Clínic, Barcelona, Spain, Institut d’Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain

  ⨯
• Vanessa Almendro,

  Affiliations Department of Medical Oncology, Hospital Clínic, Barcelona, Spain, Institut d’Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain

  ⨯
• Pedro Gascón

  * E-mail: sugarcia@clinic.ub.es (SGR); gascon@clinic.ub.es (PG)

  Affiliations Department of Medical Oncology, Hospital Clínic, Barcelona, Spain, Institut d’Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain, Department of Medicine, University of Barcelona, Barcelona, Spain

  ⨯